GDTC
CytoMed Therapeutics Limited
NASDAQ · Healthcare · Biotechnology · SG
$0.86
−2.15%Leverage
- Debt / equity
- 0.07x
- Net debt / equity
- -0.25x
- Debt / assets
- 0.06x
- Debt / EBITDA
- -0.09x
- Net debt / EBITDA
- 0.31x
Liquidity & coverage
- Current ratio
- 5.17x
- Quick ratio
- 3.66x
- Cash ratio
- 2.95x
- Interest coverage
- -209.99x
- EBITDA / interest
- -256.28x
- Working capital
- $2.3M
Cash & dividend
- FCF / debt
- -13.13x
- Cash flow / debt
- -11.16x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025